Deploymerization method for nucleic acid detection of an amplified nucleic acid target

• US 6,277,578 B1
• Filed: 10/29/1999
• Issued: 08/21/2001
• Est. Priority Date: 03/13/1998
• Status: Expired due to Fees

• Current Assignee: Promega Corporation
• Original Assignee: Promega Corporation
• Inventors: Hartnett, James Robert, Mandrekar, Michelle, Lewis, Martin K., Leippe, Donna, Shultz, John William, Andrews, Christine Ann, Welch, Roy
• Primary Examiner(s): Horlick, Kenneth R.
• Assistant Examiner(s): STRZELECKA, TERESA E
• Application Number:
  US09/430,615
• Time in Patent Office: 662 Days
• Field of Search: 435/5, 435/6, 435/91.2
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/04 Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor C12Q1/6897 takes precedence
• CPC Class Codes: C12Q 1/66 involving luciferase
• CPC Class Codes: C12Q 1/68 involving nucleic acids
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 2521/319 Exonuclease
• CPC Class Codes: C12Q 2535/107 Maxam and Gilbert method, i.e. sequential release and detection of nucleotides
• CPC Class Codes: C12Q 2535/131 Allele specific probes
• CPC Class Codes: C12Q 2537/101 Homogeneous assay format, e.g. one pot reaction
• CPC Class Codes: C12Q 2565/1015 labels being on the same oligonucleotide
• CPC Class Codes: C12Q 2565/301 Pyrophosphate (PPi)
• CPC Class Codes: C12Q 2565/627 being a mass spectrometer

Abstract

The detection of enhanced, targeted predetermined nucleic acid sequences in nucleic acid target hybrids, and the various applications of target nucleic acid enhancement are disclosed.

Claims

1. A nucleic acid assay method wherein the presence or absence of a predetermined nucleic acid target sequence is determined, and a nucleic acid target-containing sequence in a nucleic acid sample to be assayed is amplified to form an amplified nucleic acid sample prior to said determination, the improvement wherein the presence or absence of said predetermined nucleic acid target sequence is determined by steps that comprise:

(A) admixing the amplified nucleic acid sample to be assayed with one or more nucleic acid probes to form a hybridization composition, wherein the 3′

-terminal region of said nucleic acid probes (i) hybridizes with partial or total complementarity to at least one said predetermined nucleic acid target sequence when that sequence is present in the sample and (ii) includes an identifier nucleotide;

(B) maintaining said hybridization composition for a time period sufficient to form a treated sample that may contain said amplified predetermined nucleic acid target sequence hybridized with a nucleic acid probe;

(C) admixing the treated sample with a depolymerizing amount of an enzyme whose activity is to release one or more single nucleotides from the 3′

-terminus of a hybridized nucleic acid probe to form a treated reaction mixture;

(D) maintaining the treated reaction mixture for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid and release identifier nucleotides therefrom; and

(E) analyzing for the presence of released identifier nucleotides to obtain an analytical output, the analytical output indicating the presence or absence of at least one said nucleic acid target sequence in said nucleic acid sample.

2. The method according to claim 1 wherein said identifier nucleotide is a nucleoside triphosphate.

3. The method according to claim 2 wherein said nucleoside triphosphate is used to covert ADP to ATP using a nucleoside diphosphate kinase.

4. The method according to claim 3 wherein said nucleoside diphosphate kinase is encoded by a nucleic acid sequence that comprises the nucleic acid sequence of a nucleoside diphosphate kinase encoded by Pyrococcus furiosis.

5. The method according to claim 1 wherein said analytical output is obtained by luminescence spectroscopy.

6. The method according to claim 1 wherein said analytical output is obtained by fluorescence spectroscopy.

7. The method according to claim 1 wherein said analytical output is obtained by mass spectrometry.

8. The method according to claim 1 wherein said analytical output is obtained by absorbance spectroscopy.

9. The method according to claim 1 wherein said nucleic acid target-containing sequence in a nucleic acid sample is amplified by rolling circle amplification.

10. The method according to claim 1 wherein said nucleic acid target-containing sequence in a nucleic acid sample is amplified by PCR amplification.

11. The method according to claim 1 wherein said nucleic acid target-containing sequence in a nucleic acid sample is amplified by ligase chain reaction amplification.

12. An amplification and interrogation process to determine the presence or absence of a predetermined nucleic acid target sequence comprising the steps of:

(A) providing a ligation reaction solution comprising (i) a ligating amount of a ligase, (ii) a nucleic acid sample that may contain a predetermined nucleic acid target sequence wherein the nucleic acid target sequence has a 3′

-portion and a 5′

-portion, (iii) an open circle probe comprising three regions;

an open circle probe 3′

-terminal region, a linker region, and an open circle probe 5′

-terminal region, said open circle probe further including a detection primer target and an amplification primer target, the amplification primer target being downstream of the detection primer target, wherein upon hybridization between the open circle probe and the nucleic acid target sequence, the open circle probe 3′

-terminal region is complementary to a sequence of the 3′

-portion of said predetermined nucleic acid target sequence, and the open circle probe 5′

-terminal region is complementary to a sequence of the 5′

-portion of said predetermined nucleic acid target sequence, and (iv) optionally further comprising a polymerizing amount of a DNA polymerase and deoxynucleoside triphosphates when the hybridized open circle probe 3′

-terminus is not adjacent and ligatable to the hybridized open circle probe 5′

-terminus and a gap is present between those termini;

(B) maintaining the ligation reaction solution for a time period sufficient to permit filling-in of said gap, when present, and ligation of the termini of the open circle probe to form a closed circular probe and a treated ligation reaction solution;

(C) admixing said closed circular probe with an amplification primer that hybridizes with said amplification primer target, nucleoside triphosphates, and a polymerizing amount of a DNA polymerase to form a replication reaction mixture;

(D) maintaining the replication reaction mixture for a time period sufficient to permit extension of a nucleic acid strand from the amplification primer, wherein the extension product nucleic acid strand comprises an interrogation target that is complementary to the detection primer target, to form a treated replication mixture;

(E) admixing an interrogation probe with the treated replication mixture, wherein the interrogation probe is complementary to said interrogation target and comprises an identifier nucleotide in the 3′

-terminal region;

(F) denaturing the treated replication mixture to form a denatured mixture;

(G) annealing the denatured mixture to form hybrid between the interrogation probe and the interrogation target when present to form an interrogation solution;

(H) admixing a depolymerizing amount of an enzyme whose activity is to release one or more single nucleotides from the 3′

-terminus of a hybridized nucleic acid probe with the interrogation solution to form a depolymerization reaction mixture;

(I) maintaining the depolymerization reaction mixture for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid and release identifier nucleotide therefrom; and

(J) analyzing for the presence of released identifier nucleotide to obtain an analytical output, the analytical output indicating the presence or absence of said predetermined nucleic acid target sequence.

13. The process according to claim 12 wherein the depolymerizing enzyme is thermostable.

14. The process according to claim 12 wherein free nucleotide triphosphates are separated from the treated replication mixture prior to step H.

15. The process according to claim 12 wherein step H occurs before step F.

16. The process according to claim 12 wherein there is a gap present between the termini of the hybridized open circle probe, the portion of the predetermined nucleic acid target sequence between the 3′

- and 5′

-termini of the hybridized open circle probe that is opposite said gap contains three or fewer nucleotides and only nucleoside triphosphates complementary to said three or fewer nucleotides are present in said ligation reaction solution.

17. The process according to claim 12 wherein a polymerizing amount of a DNA polymerase and nucleoside triphosphates are present in said ligation reaction solution.

18. The process according to claim 12 wherein the open circle probe comprises a plurality of detection primer targets.

19. The process according to claim 12 wherein the presence or absence of a plurality of predetermined nucleic acid targets is determined using a plurality of detection probes comprising different identifier nucleotides.

20. The method according to claim 12 wherein said identifier nucleotide is a nucleoside triphosphate.

21. The method according to claim 20 wherein said nucleoside triphosphate is used to covert ADP to ATP using a nucleoside diphosphate kinase.

22. The method according to claim 21 wherein said nucleoside diphosphate kinase is encoded by a nucleic acid sequence that comprises the nucleic acid sequence of a nucleoside diphosphate kinase encoded by Pyrococcus furiosis.

23. The method according to claim 12 wherein said analytical output is obtained by luminescence spectroscopy.

24. The method according to claim 12 wherein said analytical output is obtained by fluorescence spectroscopy.

25. The method according to claim 12 wherein said analytical output is obtained by mass spectrometry.

26. The method according to claim 12 wherein said analytical output is obtained by absorbance spectroscopy.

27. The method according to claim 12 wherein said nucleic acid sample is obtained from a biological sample.

28. The method according to claim 27 wherein said predetermined nucleic acid target sequence is a microbial or viral nucleic acid.

29. The method according to claim 28 wherein said predetermined nucleic acid target sequence is a viral nucleic acid and the magnitude of the analytical output from a predetermined amount of said biological fluid provides a measure of the viral load in the biological sample.

30. The method according to claim 12 wherein said nucleic acid sample is obtained from a food source.

31. The method according to claim 30 wherein said food source is a plant.

32. The method according to claim 31 wherein said predetermined nucleic acid target sequence is a sequence non-native to the genome of said plant.

33. An amplification and interrogation process to determine the presence or absence of a predetermined nucleic acid target sequence having a 3′

-portion and a 5′

-portion comprising the steps of;

(A) providing a ligation reaction solution comprising (i) ligating amount of a ligase, (ii) a nucleic acid sample that may contain a predetermined nucleic acid target sequence wherein the nucleic acid target sequence has a 3′

-portion and a 5′

-portion, (iii) a pair of ligation probes, the first ligation probe being complementary to the 5′

-portion of the nucleic acid target sequence and the second ligation probe being complementary to the 3′

-portion of the nucleic acid target sequence, wherein said first ligation probe includes an amplification primer target and a 3′

-terminus and said second ligation probe includes a detection primer target and a 5′

-terminus, wherein upon hybridization between the pair of ligation probes and the nucleic acid target sequence, the second ligation probe is complementary to a sequence of the 3′

-portion of said predetermined nucleic acid target sequence, and the first ligation probe is complementary to a sequence of the 5′

-portion of said predetermined nucleic acid target sequence, and (iv) optionally further comprising a polymerizing amount of a DNA polymerase and deoxynucleoside triphosphates when the hybridized second ligation probe 3′

-terminus is not adjacent and ligatable to the hybridized first ligation probe 5′

-terminus and a gap is present between those termini;

(B) maintaining the ligation reaction solution for a time period sufficient to permit filling-in of said gap, when present, and ligation of the termini of the pair of ligation probes to form a ligated probe and a treated ligation reaction solution;

(C) admixing said ligated probe with an amplification primer that hybridizes with said amplification primer target, nucleoside triphosphates, and a polymerizing amount of a DNA polymerase to form a replication reaction mixture;

(D) maintaining the replication reaction mixture for a time period sufficient to permit extension of a nucleic acid strand from the amplification primer, wherein the extension product nucleic acid strand comprises a interrogation target that is complementary to the detection primer target, to form a treated amplification mixture;

(E) admixing an interrogation probe with the treated amplification mixture, wherein the interrogation probe is complementary to said interrogation target and comprises an identifier nucleotide in the 3′

-terminal region;

(F) denaturing the treated amplification mixture to form a denatured mixture;

(G) annealing the denatured mixture to form hybrid between the interrogation probe and the interrogation target when present to form an interrogation solution;

(H) admixing a depolymerizing amount of an enzyme whose activity is to release one or more single nucleotides from the 3′

-terminus of a hybridized nucleic acid probe with the interrogation solution to form a depolymerization reaction mixture;

(I) maintaining the depolymerization reaction mixture for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid and release identifier nucleotide therefrom; and

(J) analyzing for the release of identifier nucleotide to obtain an analytical output, the analytical output indicating the presence or absence of said predetermined nucleic acid target sequence.

34. The process according to claim 33 wherein the depolymerizing enzyme is thermostable.

35. The process according to claim 33 wherein free nucleotide triphosphates are separated from the treated amplification mixture prior to step H.

36. The process according to claim 33 wherein step H occurs before step F.

37. The process according to claim 33 wherein there is a gap present between the termini of the hybridized pair of ligation probes, the portion of the predetermined nucleic acid target sequence between the 3′

- and 5′

-termini of the hybridized pair of ligation probes that is opposite said gap contains three or fewer nucleotides and only nucleoside triphosphates complementary to said three or fewer nucleotides are present in said ligation reaction solution.

38. The process according to claim 33 wherein a polymerizing amount of a DNA polymerase and nucleoside triphosphates are present in said ligation reaction solution.

39. The process according to claim 33 wherein said second ligation probe comprises a plurality of detection primer targets.

40. The process according to claim 33 wherein the presence or absence of a plurality of predetermined nucleic acid targets is determined using a plurality of detection probes comprising different identifier nucleotides.

41. The method according to claim 33 wherein said analytical output is obtained by luminescence spectroscopy.

42. The method according to claim 33 wherein said analytical output is obtained by fluorescence spectroscopy.

43. The method according to claim 33 wherein said analytical output is obtained by mass spectrometry.

44. The method according to claim 33 wherein said analytical output is obtained by absorbance spectroscopy.

45. The method according to claim 33 wherein said nucleic acid sample is obtained from a biological sample.

46. The method according to claim 45 wherein said predetermined nucleic acid target sequence is a microbial or viral nucleic acid.

47. The method according to claim 46 wherein said predetermined nucleic acid target sequence is a viral nucleic acid and the magnitude of the analytical output from a predetermined amount of said biological fluid provides a measure of the viral load in the biological sample.

48. The method according to claim 33 wherein said nucleic acid sample is obtained from a food source.

49. The method according to claim 48 wherein said food source is a plant.

50. The method according to claim 49 herein said predetermined nucleic acid target sequence is a sequence non-native to the genome of said plant.

51. A method for determining the presence or absence of a restriction endonuclease recognition sequence in a nucleic acid sample that comprises the steps of:

(A) providing a treated sample that may contain a hybridized nucleic acid target that is a cleaved restriction endonuclease recognition sequence that includes an identifier nucleotide in the restriction endonuclease recognition sequence;

(B) admixing the treated sample with a depolymerizing amount of an enzyme whose activity is to release one or more single nucleotides from the 3′

-terminus of a restriction endonuclease recognition sequence to form a treated reaction mixture;

(C) maintaining the treated reaction mixture for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid and release identifier nucleotide therefrom; and

(D) analyzing for the presence of released identifier nucleotide to obtain an analytical output, the analytical output indicating the presence or absence of said restriction endonuclease recognition sequence.

52. The method of claim 51 including the further steps of forming a treated sample by:

(A) providing an endonuclease cleavage reaction solution comprising a nucleic acid sample and a restriction endonuclease enzyme specific for the restriction endonuclease recognition sequence; and

(B) maintaining the endonuclease cleavage reaction solution for a time period sufficient for the restriction endonuclease enzyme to cleave the restriction endonuclease recognition sequence to form a treated sample.

53. The method of claim 51 including the further step of amplifying a nucleic acid target sequence in a nucleic acid sample prior to providing said restriction endonuclease recognition sequence.

54. The method of claim 53 wherein said nucleic acid target sequence is amplified by the further steps of:

(A) admixing a crude nucleic acid sample with PCR amplification primers that are complementary to regions upstream and downstream of the nucleic acid target sequence and a template-dependent polymerase to form an amplification sample mixture wherein either the nucleic acid target sequence or the PCR amplification primers includes a restriction endonuclease recognition sequence;

(B) maintaining the amplification sample mixture for a time period sufficient to denature the nucleic acid target sequence to form a denatured amplification reaction mixture;

(C) annealing the denatured amplification reaction mixture for a time period sufficient for PCR amplification primers to anneal to the nucleic acid target sequence to form an amplification reaction mixture; and

(D) maintaining the amplification reaction mixture for a time period sufficient to permit the template-dependent polymerase to extend the nucleic acid from the PCR primers to form an amplified nucleic acid sample.

55. The method according to claim 51 wherein said identifier nucleotide is a nucleoside triphosphate.

56. The method according to claim 55 wherein said nucleoside triphosphate is used to covert ADP to ATP using a nucleoside diphosphate kinase.

57. The method according to claim 56 wherein said nucleoside diphosphate kinase is encoded by a nucleic acid sequence that comprises the nucleic acid sequence of a nucleoside diphosphate kinase encoded by Pyrococcus furiosis.

58. The method according to claim 51 wherein said analytical output is obtained by luminescence spectroscopy.

59. The method according to claim 51 wherein said analytical output is obtained by absorbance spectrometry.

60. The method according to claim 51 wherein said analytical output is obtained by fluorescence spectroscopy.

61. The method according to claim 51 wherein said analytical output is obtained by mass spectrometry.

62. The method according to claim 51 wherein said enzyme whose activity is to release nucleotides is a template-dependent polymerase that, in the presence of pyrophosphate ions, depolymerizes hybridized nucleic acids whose bases in the 3′

-terminal region are completely complementary to bases of said nucleic acid target.